[Thymectomy in the management of myasthenia].
D000293:Adolescent; D000324:Adrenocorticotropic Hormone / Q000627:therapeutic use; D000328:Adult; D000367:Age Factors; D002648:Child; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004357:Drug Synergism; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007362:Intensive Care Units; D008297:Male; D008875:Middle Aged; D009157:Myasthenia Gravis / Q000188:drug therapy / Q000473:pathology / Q000628:therapy*; D011182:Postoperative Care; D011300:Preoperative Care; D011379:Prognosis; D013256:Steroids / Q000627:therapeutic use; D013934:Thymectomy
D002800:Cholinesterase Inhibitors; D007166:Immunosuppressive Agents; D013256:Steroids; D000324:Adrenocorticotropic Hormone
Die Thymektomie im Behandlungsplan der Myasthenie.